{"_id":"s2yFM9oPPFpMs4vL3","bibbaseid":"solomon-felip-bar-berchem-bazhenova-saintigny-girard-sulaiman-etal-abstractct223survivalprolongationbyrationaleinnovativegenomicsspringaninternationalwinconsortiumphaseiiiproofofconceptstudytoexplorethesafetyandefficacyofatritherapyapproachusingavelumabpalbociclibandaxitinibinadvancedmetastaticnonsmallcelllungcancernsclcwithintegratedgenomicandtranscriptomiccorrelates-2019","author_short":["Solomon, B.","Felip, E.","Bar, J.","Berchem, G.","Bazhenova, L.","Saintigny, P.","Girard, N.","Sulaiman, R.","Bresson, C.","Wunder, F.","others"],"bibdata":{"bibtype":"article","type":"article","title":"Abstract CT223: Survival Prolongation by Rationale INnovative Genomics (SPRING): An international WIN Consortium Phase I/II proof-of-concept study to explore the safety and efficacy of a tri-therapy approach using avelumab, palbociclib and axitinib in advanced/metastatic non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates","author":[{"propositions":[],"lastnames":["Solomon"],"firstnames":["Benjamin"],"suffixes":[]},{"propositions":[],"lastnames":["Felip"],"firstnames":["Enriqueta"],"suffixes":[]},{"propositions":[],"lastnames":["Bar"],"firstnames":["Jair"],"suffixes":[]},{"propositions":[],"lastnames":["Berchem"],"firstnames":["Guy"],"suffixes":[]},{"propositions":[],"lastnames":["Bazhenova"],"firstnames":["Lyudmila"],"suffixes":[]},{"propositions":[],"lastnames":["Saintigny"],"firstnames":["Pierre"],"suffixes":[]},{"propositions":[],"lastnames":["Girard"],"firstnames":["Nicolas"],"suffixes":[]},{"propositions":[],"lastnames":["Sulaiman"],"firstnames":["Raed"],"suffixes":[]},{"propositions":[],"lastnames":["Bresson"],"firstnames":["Catherine"],"suffixes":[]},{"propositions":[],"lastnames":["Wunder"],"firstnames":["Fanny"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["others"],"suffixes":[]}],"journal":"Cancer Research","volume":"79","number":"13_Supplement","pages":"CT223–CT223","year":"2019","publisher":"The American Association for Cancer Research","bibtex":"@article{solomon2019abstract,\n title={Abstract CT223: Survival Prolongation by Rationale INnovative Genomics (SPRING): An international WIN Consortium Phase I/II proof-of-concept study to explore the safety and efficacy of a tri-therapy approach using avelumab, palbociclib and axitinib in advanced/metastatic non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates},\n author={Solomon, Benjamin and Felip, Enriqueta and Bar, Jair and Berchem, Guy and Bazhenova, Lyudmila and Saintigny, Pierre and Girard, Nicolas and Sulaiman, Raed and Bresson, Catherine and Wunder, Fanny and others},\n journal={Cancer Research},\n volume={79},\n number={13\\_Supplement},\n pages={CT223--CT223},\n year={2019},\n publisher={The American Association for Cancer Research}\n}\n\n","author_short":["Solomon, B.","Felip, E.","Bar, J.","Berchem, G.","Bazhenova, L.","Saintigny, P.","Girard, N.","Sulaiman, R.","Bresson, C.","Wunder, F.","others"],"key":"solomon2019abstract","id":"solomon2019abstract","bibbaseid":"solomon-felip-bar-berchem-bazhenova-saintigny-girard-sulaiman-etal-abstractct223survivalprolongationbyrationaleinnovativegenomicsspringaninternationalwinconsortiumphaseiiiproofofconceptstudytoexplorethesafetyandefficacyofatritherapyapproachusingavelumabpalbociclibandaxitinibinadvancedmetastaticnonsmallcelllungcancernsclcwithintegratedgenomicandtranscriptomiccorrelates-2019","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/network/files/QpppF92hGWuJ5y5Eh","dataSources":["u6vCg6hdprqERxouE","tpPgfZjgEFYmWeP27","B5khaFiqcrF2ex5G6"],"keywords":[],"search_terms":["abstract","ct223","survival","prolongation","rationale","innovative","genomics","spring","international","win","consortium","phase","proof","concept","study","explore","safety","efficacy","tri","therapy","approach","using","avelumab","palbociclib","axitinib","advanced","metastatic","non","small","cell","lung","cancer","nsclc","integrated","genomic","transcriptomic","correlates","solomon","felip","bar","berchem","bazhenova","saintigny","girard","sulaiman","bresson","wunder","others"],"title":"Abstract CT223: Survival Prolongation by Rationale INnovative Genomics (SPRING): An international WIN Consortium Phase I/II proof-of-concept study to explore the safety and efficacy of a tri-therapy approach using avelumab, palbociclib and axitinib in advanced/metastatic non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates","year":2019}